Trial Profile
Effects of add-on cilostazol on tachyarrhythmia in patients undergoing PCI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Oct 2013
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary) ; Antiplatelets
- Indications Cardiovascular disorders; Coronary artery disease; Embolism and thrombosis
- Focus Adverse reactions
- 02 Oct 2013 New trial record
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.